Literature DB >> 1201243

The intercellular content of the three transcobalamins at various stages of normal and leukaemic myleoid cell development.

J Zittoun, J Marquet, R Zittoun.   

Abstract

A study of the three serum transcobalamins (TC) in myeloproliferative disorders and acute leukaemia has suggested a granulocyte origin for the three binders; the later stages of this cell line might be releasing 'TC I' and 'TC III' while 'TC II' which is increased in sera from patients with acute myelogenous leukaemia, probably originates at least in part from myeloblasts. The intracellular content of each TC has been studied in normal and leukaemic bone marrow cells after separation on a discontinuous bovine serum albumin gradient. Myeloblasts contain a TC II-like protein almost exclusively but promyelocytes contain a TC I-like protein which increases as the cells mature whilst 'TC II' decreases. A TC III-like binder parallels 'TC I' but appears later and reaches a maximum in the polymorphonuclear cells. In various types of leukaemia, abnormal TC distributions are related either to marrow replacement by the blast cells or to a disorder of the maturation process in the leukaemic cell line.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201243     DOI: 10.1111/j.1365-2141.1975.tb00861.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Chronic neutrophilic leukemia. A study of four cases.

Authors:  R Zittoun; D Réa; L H Ngoc; S Ramond
Journal:  Ann Hematol       Date:  1994-02       Impact factor: 3.673

2.  Hypercobalaminemia induced by an energy drink after total gastrectomy: a case report.

Authors:  Kazuhiro Takahashi; Shigeki Tsukamoto; Yuta Kakizaki; Ken Saito; Nobuhiro Ohkohchi; Katsu Hirayama
Journal:  J Rural Med       Date:  2013-07-02

3.  The return of the Scarlet Pimpernel: cobalamin in inflammation II - cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS.

Authors:  Carmen Wheatley
Journal:  J Nutr Environ Med       Date:  2007-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.